PREVAIL THERAPEUTICS

prevail-therapeutics-logo

Prevail Therapeutics is a biotechnology company focused on developing novel gene therapies for patients with Parkinsonโ€™s disease and other neurodegenerative diseases. Prevail was launched in 2017 by The Silverstein Foundation for Parkinsonโ€™s with GBA, REGENXBIO, and OrbiMed, and is headquartered in New York, NY.

#SimilarOrganizations #People #Financial #Website #More

PREVAIL THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Health Diagnostics Therapeutics

Founded:
2017-01-01

Address:
New York, New York, United States

Country:
United States

Website Url:
http://www.prevailtherapeutics.com

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
129 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

affinia-therapeutics-logo

Affinia Therapeutics

Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.

cedilla-therapeutics-logo

Cedilla Therapeutics

Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.

disarm-therapeutics-logo

Disarm Therapeutics

Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.

expansion-therapeutics-logo

Expansion Therapeutics

Expansion Therapeutics is a biotechnology company focused on developing transformative oral medicines for severe RNA-mediated diseases.

fulcrum-therapeutics-logo

Fulcrum Therapeutics

Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.

modis-therapeutics-logo

Modis Therapeutics

Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.

neurovation-labs-logo

Neurovation Labs

Neurovation Labs is a biotech company focused CNS disorders, starting first with Post-traumatic Stress Disorder (PTSD).

ray-therapeutics-logo

Ray Therapeutics

Ray Therapeutics is a biotech company developing optogenetic gene therapies for patients with blinding diseases.

ribon-therapeutics-logo

Ribon Therapeutics

Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.

vigil-neuroscience-logo

Vigil Neuroscience

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.


Current Advisors List

asa-abeliovich_image

Asa Abeliovich Board of Directors @ Prevail Therapeutics
Board_member

Current Employees Featured

david-litwack_image

David Litwack
David Litwack Director of Regulatory Strategy & Communications @ Prevail Therapeutics
Director of Regulatory Strategy & Communications
2018-09-01

franz-hefti_image

Franz Hefti
Franz Hefti CEO @ Prevail Therapeutics
CEO
2021-03-01

jeffrey-sevigny_image

Jeffrey Sevigny
Jeffrey Sevigny Chief Medical Officer @ Prevail Therapeutics
Chief Medical Officer
2018-03-01

yong-dai_image

Yong Dai
Yong Dai Chief Technology Officer @ Prevail Therapeutics
Chief Technology Officer
2019-01-01

emily-minkow_image

Emily Minkow
Emily Minkow Chief Business Officer @ Prevail Therapeutics
Chief Business Officer
2018-11-01

brett-kaplan_image

Brett Kaplan
Brett Kaplan Chief Financial Officer @ Prevail Therapeutics
Chief Financial Officer
2018-11-01

Founder


asa-abeliovich_image

Asa Abeliovich

Stock Details


Company's stock symbol is NASDAQ:PRVL

Investors List

ecor1-capital_image

EcoR1 Capital

EcoR1 Capital investment in Series B - Prevail Therapeutics

alexandria-venture-investments_image

Alexandria Venture Investments

Alexandria Venture Investments investment in Series B - Prevail Therapeutics

adage-capital-management_image

Adage Capital Management

Adage Capital Management investment in Series B - Prevail Therapeutics

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series B - Prevail Therapeutics

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Series B - Prevail Therapeutics

biotechnology-value-fund_image

Biotechnology Value Fund

Biotechnology Value Fund investment in Series B - Prevail Therapeutics

pontifax_image

Pontifax

Pontifax investment in Series B - Prevail Therapeutics

omega-funds_image

Omega Funds

Omega Funds investment in Series B - Prevail Therapeutics

surveyor-capital_image

Surveyor Capital

Surveyor Capital investment in Series B - Prevail Therapeutics

abbvie-biotech-ventures_image

AbbVie Biotech Ventures

AbbVie Biotech Ventures investment in Series B - Prevail Therapeutics

Official Site Inspections

http://www.prevailtherapeutics.com Semrush global rank: 4.02 M Semrush visits lastest month: 3.07 K

  • Host name: rssd3234.webaccountserver.com
  • IP address: 192.245.157.40
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Prevail Therapeutics" on Search Engine